Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)

BACKGROUND: Vivax malaria is the predominant form of malaria outside Africa, affecting about 14 million people worldwide, with about 2.5 billion people exposed. Development of a Plasmodium vivax vaccine is a priority, and merozoite surface protein 7 (MSP-7) has been proposed as a plausible candidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chew Weng, Jongwutiwes, Somchai, Putaporntip, Chaturong, Jackson, Andrew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567670/
https://www.ncbi.nlm.nih.gov/pubmed/31196098
http://dx.doi.org/10.1186/s12936-019-2826-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567670/
https://www.ncbi.nlm.nih.gov/pubmed/31196098
http://dx.doi.org/10.1186/s12936-019-2826-7

Ejemplares similares